Home Newsfeeds Compass Point Maintains Neutral on Argo Blockchain, Lowers Price Target to $1

Compass Point Maintains Neutral on Argo Blockchain, Lowers Price Target to $1

Compass Point analyst Chase White maintains Argo Blockchain (NASDAQ:ARBK) with a Neutral and lowers the price target from $4.5 to $1.

byBenzinga Newsdesk

November 1, 2022

1 minute read

Compass Point analyst Chase White maintains Argo Blockchain (NASDAQ:ARBK) with a Neutral and lowers the price target from $4.5 to $1.

Mirion Technologies Awarded Strategic Design Contract For X-Energy’s Small Modular Reactor

By Happy Mohamed

August 15, 8:16 AM

Agreement Focused on Unique Burn Up Measurement System (BUMS) in Development of the Xe-100 High-Temperature Gas-Cooled Reactor Mirion Technologies (NYSE:MIR), a leading provider of advanced radiation safety solutions,

MIR

FDA Refuses Neurology-Focused Clene’s Accelerated Approval For Amyotrophic Lateral Sclerosis Treatment, Shares Fall

By Vandana Singh

December 21, 2:02 PM

Clene Inc (NASDAQ: CLNN) provided an amyotrophic lateral sclerosis (ALS) regulatory update from its recent meeting with the FDA to discuss CNM-Au8 for ALS, presenting initial clinical and Neurofilament Light Chain (NfL) biomarker results from the completed

CLNN

TD Holdings, Inc. Announces Reverse Stock Split Effective Today

By Benzinga Newsdesk

August 17, 7:18 AM

TD Holdings, Inc. (NASDAQ:GLG) (the "Company"), a commodities trading service provider in China, today announced that its common stock is expected to begin trading when the markets open on a reverse stock

GLG

If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,100 Today

By Benzinga Insights

August 22, 10:40 AM

Nordson (NASDAQ:NDSN) has outperformed the market over the past 20 years by 8.69% on an annualized basis producing an average annual return of 16.51%. Currently, Nordson has a market capitalization of $13.81 billion.

NDSN

Compass Point Maintains Neutral on Argo Blockchain, Lowers Price Target to $1

Related Posts

Mirion Technologies Awarded Strategic Design Contract For X-Energy’s Small Modular Reactor

FDA Refuses Neurology-Focused Clene’s Accelerated Approval For Amyotrophic Lateral Sclerosis Treatment, Shares Fall

TD Holdings, Inc. Announces Reverse Stock Split Effective Today

If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,100 Today